Morgan Stanley’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
2023
Q4
$545K Buy
2023
Q3
$182K Buy
2023
Q2
$89.9K Buy
2023
Q1
$86.2K Sell
2022
Q4
$90.9K Buy
2022
Q3
$121K Sell
2022
Q2
$168K Buy
2022
Q1
$207K Buy
2021
Q4
$211K Buy
2021
Q3
$141K Buy
2021
Q2
$274K Buy
2021
Q1
$275K Sell
2020
Q4
$490K Buy
2020
Q3
$206K Buy